哺乳動物細胞發酵技術市場規模、佔有率和成長分析：按產品類型、細胞株類型、應用、企業規模、最終用戶、技術類型和地區分類－2026-2033年產業預測

2024 年全球哺乳動物細胞發酵技術市場價值為 522 億美元，預計到 2025 年將從 567.9 億美元成長到 2033 年的 1115.1 億美元，在預測期（2026-2033 年）內複合年成長率為 8.8%。

哺乳動物細胞發酵技術市場的發展動力源於對複雜生物製劑日益成長的需求，這些生物製劑需要進行微生物宿主無法實現的、類似人類的高級轉譯後修飾。該市場涵蓋哺乳動物細胞培養的關鍵組件，例如設備、細胞株、培養基和製程開發服務，這些組件對於單株抗體、重組蛋白和細胞療法的生產至關重要。一次性生物反應器和可擴展灌注等技術進步簡化了開發流程並降低了成本，促使生物製藥公司採用高效價CHO細胞株和連續灌注技術。此外，人工智慧在生產過程中的應用，透過將即時數據與預測模型相結合來最佳化培養條件，從而提高了效率。這種協同作用增強了製程控制和可重複性，推動了該領域的投資，並加快了監管核准。

全球哺乳動物細胞發酵技術市場的成長要素

全球哺乳動物細胞發酵技術市場的主要促進因素之一是生物製藥，特別是單株抗體和治療性蛋白質日益成長的需求。隨著生物技術產業的不斷發展，人們越來越關注開發更有效、更具標靶性的治療方法，以治療包括癌症和自體免疫疾病在內的各種慢性疾病。生物製藥產量的激增需要更先進的發酵技術，以最大限度地提高產量、改善產品品質並簡化生產流程。此外，個人化醫療的趨勢也增加了對靈活生物製造解決方案的需求，進一步推動了製藥業這一領域的成長。

全球哺乳動物細胞發酵技術市場面臨的限制因素

全球哺乳動物細胞發酵技術市場的主要限制因素是發酵系統引進和維護所需的高昂營運成本和資本投資。這些成本可能會阻礙中小企業投資先進的生物製程技術。此外，嚴格的監管要求和對專業技術人員的需求也會進一步增加這些技術引進的難度。針對不同細胞株最佳化發酵製程的複雜性，以及規模化生產和確保一致性方面的挑戰，都可能導致研發週期延長，對市場成長潛力產生負面影響，並可能限制所有相關人員的參與。

哺乳動物細胞發酵技術的全球市場趨勢

全球哺乳動物細胞發酵技術市場正呈現生物製程整合的顯著趨勢。相關人員致力於在最大限度減少運作空間的同時，提高單位體積的生產效率。這促使高密度細胞培養和連續灌注技術得到廣泛應用，在維持產品品質穩定的同時，提高產品產量。這些創新推動了設備和精密製程控制技術的進步，加強了製劑研發和生產部門之間的協作。此外，對先進分析和製程建模的投資也在不斷增加，這對於建立可靠的放大策略以及確保在不同治療領域實現高效的技術轉移至關重要，最終將提升生物製藥的生產效率。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢
• 價值鏈分析
• 案例研究
• 技術評估
• 客戶和採購標準分析
• 管道分析
• 疾病流行病學

全球哺乳動物細胞發酵技術市場規模：依產品類型分類

• 生物反應器
• 細胞培養基
• 試劑和緩衝溶液
• 過濾系統
• 免洗系統
• 其他

全球哺乳動物細胞發酵技術市場規模：細胞株類型分類

• CHO細胞
• HEK細胞
• BHK 細胞
• 融合瘤
• 其他

全球哺乳動物細胞發酵技術市場規模：按應用領域分類

• 單株抗體生產
• 疫苗生產
• 重組蛋白生產
• 細胞和基因治療
• 幹細胞研究
• 其他

全球哺乳動物細胞發酵技術市場規模：依企業規模分類

• 調查量表
• 中試規模
• 商業規模

全球哺乳動物細胞發酵技術市場規模：依最終用戶分類

• 生物製藥公司
• 合約研發生產組織（CDMO）
• 學術研究機構
• 生技公司

全球哺乳動物細胞發酵技術市場規模：依技術類型分類

• 分批式發酵
• 補料分批發酵
• 灌注發酵

全球哺乳動物細胞發酵技術市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Thermo Fisher Scientific
• Sartorius
• Danaher Corporation
• Merck KGaA
• Cytiva
• Eppendorf
• Lonza
• Getinge
• Applikon Biotechnology
• Pierre Guerin
• ABEC
• PBS Biotech
• Distek
• Solaris Biotechnology
• Infors HT
• Broadley-James
• Meissner Filtration Products
• Repligen
• Bionet
• CelliGen Bioprocess Solutions

結論與建議

Global Mammalian Cell Fermentation Technology Market size was valued at USD 52.2 Billion in 2024 and is poised to grow from USD 56.79 Billion in 2025 to USD 111.51 Billion by 2033, growing at a CAGR of 8.8% during the forecast period (2026-2033).

The market for mammalian cell fermentation technology is significantly influenced by the rising demand for complex biologics, which require sophisticated human-like post-translational modifications unattainable from microbial hosts. This market encompasses essential components for culturing mammalian cells, including equipment, cell lines, media, and process development services critical for producing monoclonal antibodies, recombinant proteins, and cell therapies. Advancements like single-use bioreactors and scalable perfusion have streamlined development and reduced costs, prompting biopharma companies to adopt high-titer CHO cell lines and continuous perfusion. Moreover, the integration of AI in production is enhancing efficiency by linking real-time data with predictive models to optimize culture conditions. This synergy supports better process control and reproducibility, driving investment and facilitating rapid regulatory approvals in the sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Mammalian Cell Fermentation Technology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Mammalian Cell Fermentation Technology Market Segments Analysis

Global mammalian cell fermentation technology market is segmented by product type, cell line type, application, scale of operation, end user, technology type and region. Based on product type, the market is segmented into Bioreactors, Cell Culture Media, Reagents & Buffers, Filtration Systems, Single-Use Systems and Others. Based on cell line type, the market is segmented into CHO Cells, HEK Cells, BHK Cells, Hybridoma Cells and Others. Based on application, the market is segmented into Monoclonal Antibodies Production, Vaccine Production, Recombinant Protein Production, Cell & Gene Therapy, Stem Cell Research and Others. Based on scale of operation, the market is segmented into Research Scale, Pilot Scale and Commercial Scale. Based on end user, the market is segmented into Biopharmaceutical Companies, Contract Development & Manufacturing Organizations (CDMOs), Academic & Research Institutes and Biotechnology Companies. Based on technology type, the market is segmented into Batch Fermentation, Fed-Batch Fermentation and Perfusion Fermentation. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Mammalian Cell Fermentation Technology Market

One of the key market drivers for the global mammalian cell fermentation technology market is the rising demand for biopharmaceuticals, particularly monoclonal antibodies and therapeutic proteins. As the biotechnology industry continues to advance, there is an increasing focus on developing more effective and targeted therapies for various chronic diseases, including cancer and autoimmune disorders. This surge in biopharmaceutical production necessitates more sophisticated fermentation technologies that can maximize yield, enhance product quality, and streamline manufacturing processes. Furthermore, the trend towards personalized medicine amplifies the need for flexible biomanufacturing solutions, further propelling growth in this segment of the pharmaceutical industry.

Restraints in the Global Mammalian Cell Fermentation Technology Market

A significant market restraint for the global mammalian cell fermentation technology market is the high operational and capital costs associated with the setup and maintenance of fermentation systems. These costs can deter small and medium-sized enterprises from investing in advanced bioprocessing technologies. Additionally, stringent regulatory requirements and the need for specialized skilled labor can further complicate the adoption of such technologies. The complexity of optimizing fermentation processes for different cell lines and the challenges in scale-up and consistency can lead to an extended development timeline, negatively impacting the market's growth potential and limiting its accessibility to all stakeholders.

Market Trends of the Global Mammalian Cell Fermentation Technology Market

The Global Mammalian Cell Fermentation Technology market is witnessing a significant trend towards bioprocess intensification, where stakeholders focus on enhancing volumetric productivity while minimizing operational footprints. This has led to the adoption of high cell density cultures and continuous perfusion techniques, facilitating greater product yields alongside consistent quality. Such innovations drive equipment advancements and sophisticated process controls, fostering closer collaboration between formulation developers and manufacturing departments. Furthermore, there is an increasing investment in advanced analytics and process modeling, essential for establishing reliable scale-up strategies and ensuring efficient technology transfer across various therapeutic modalities, ultimately promoting more efficient biopharmaceutical production.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape
• Value Chain Analysis
• Case Studies
• Technology Assessment
• Customer & Buying Criteria Analysis
• Pipeline Analysis
• Disease Epidemiology

Global Mammalian Cell Fermentation Technology Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Bioreactors
• Cell Culture Media
• Reagents & Buffers
• Filtration Systems
• Single-Use Systems
• Others

Global Mammalian Cell Fermentation Technology Market Size by Cell Line Type & CAGR (2026-2033)

• Market Overview
• CHO Cells
• HEK Cells
• BHK Cells
• Hybridoma Cells
• Others

Global Mammalian Cell Fermentation Technology Market Size by Application & CAGR (2026-2033)

• Market Overview
• Monoclonal Antibodies Production
• Vaccine Production
• Recombinant Protein Production
• Cell & Gene Therapy
• Stem Cell Research
• Others

Global Mammalian Cell Fermentation Technology Market Size by Scale of Operation & CAGR (2026-2033)

• Market Overview
• Research Scale
• Pilot Scale
• Commercial Scale

Global Mammalian Cell Fermentation Technology Market Size by End User & CAGR (2026-2033)

• Market Overview
• Biopharmaceutical Companies
• Contract Development & Manufacturing Organizations (CDMOs)
• Academic & Research Institutes
• Biotechnology Companies

Global Mammalian Cell Fermentation Technology Market Size by Technology Type & CAGR (2026-2033)

• Market Overview
• Batch Fermentation
• Fed-Batch Fermentation
• Perfusion Fermentation

Global Mammalian Cell Fermentation Technology Market Size & CAGR (2026-2033)

• North America (Product Type, Cell Line Type, Application, Scale of Operation, End User, Technology Type)
  • US
  • Canada
• Europe (Product Type, Cell Line Type, Application, Scale of Operation, End User, Technology Type)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Cell Line Type, Application, Scale of Operation, End User, Technology Type)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Cell Line Type, Application, Scale of Operation, End User, Technology Type)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Cell Line Type, Application, Scale of Operation, End User, Technology Type)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Thermo Fisher Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cytiva
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eppendorf
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Applikon Biotechnology
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pierre Guerin
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ABEC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PBS Biotech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Distek
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Solaris Biotechnology
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Infors HT
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Broadley-James
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meissner Filtration Products
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Repligen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bionet
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CelliGen Bioprocess Solutions
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations